Immunic, Inc.
IMUX· Nasdaq
Released Mar 7, 2017, after the close
10-K filed Mar 7, 2017, 66 days after period end · 0001280776-17-000010
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Net Income | -$11.73M | -$9.86M | -$13.95M | -$10.24M |
| EPS Diluted | -$0.37 | -$0.34 | -$0.59 | -$22.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR